| Dr Hunter Kane Steward, MD | |
|
52 W Underwood St # Mp31, Orlando, FL 32806-1110 | |
| (321) 841-5111 | |
| Not Available |
| Full Name | Dr Hunter Kane Steward |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 52 W Underwood St # Mp31, Orlando, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013658327 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | TRN37791 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hunter Kane Steward, MD 52 W Underwood St # Mp31, Orlando, FL 32806-1110 Ph: (989) 600-4900 | Dr Hunter Kane Steward, MD 52 W Underwood St # Mp31, Orlando, FL 32806-1110 Ph: (321) 841-5111 |
News Archive
In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule I drug-one with no known medical potential-to a schedule IV drug such as prescription sleep aids, but with tighter control.
Myconostica Ltd, the UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today presented positive data from a multi-centre prospective evaluation of MycAssay Pneumocystis, the Company's CE marked diagnostic product for detection of Pneumocystis DNA in respiratory samples.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
Researchers at the University of Pittsburgh School of Medicine have identified two new classes of RNAs that are closely associated with a protein known to be a prognostic biomarker for breast cancer and could play a role in progression of prostate cancer.
Today's headlines include analysis of how this year's health reform debate is shaping other national policy initiatives and the upcoming mid-term elections.
› Verified 5 days ago
Landon Lichtman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-303-1940 | |
Dr. Julian Andrew Trivino, D.O., M.S. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7727 Lake Underhill Rd, Orlando, FL 32822 Phone: 407-303-6413 | |
Ramon H Nunez, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-303-5600 | |
Dr. Steve Wahel Hilwa, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 86 W Underwood St, Suite 200, Orlando, FL 32806 Phone: 407-237-6329 Fax: 407-649-3083 | |
Dr. Kenneth Vernon Slack, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7727 Lake Underhill Rd, Orlando, FL 32822 Phone: 407-303-6413 | |
Marc Santambrosio, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-303-5600 |